社区

There is a new bear roaming the Apple orchard. Could Apple stock dip about 30% from current levels, as one Wall Street analyst argues?Anew bear has emerged from its cave. New Street’s Pierre Ferragu believes that Apple stock is now a sell, downgraded from his previous neutral stance, and that shares could sink by nearly 30% from current levels to only $90.The Apple Maven gets inside the mind of this Wall Street skeptic to better understand the potential risks of investing in Apple stock today.Pi

The market for initial public offerings has recently delivered some great first-day gains for investors who were able to get shares before the companies went public.That left us with 11 names. First up:CureVac, which was the screen’s best-performing IPO and had a total return of 596.75%. CureVac specializes in the messenger RNA, or mRNA, technology that is the basis of several leading Covid-19 vaccine programs. The German biotech company went public inAugust at $16 a shareand soared 249% in its